High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease

References

• AltschulRHofferAStephenJDInfluence of Nicotinic Acid on Serum Cholesterol in ManArch Biochem Biophys1955545589
   PubMed Web of Science ®Google Scholar
• AmeliSHultgardh-NilssonACercekBRecombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbitsCirculation1994901935417923682
   PubMed Web of Science ®Google Scholar
• AndersonSPDunnCLaughterAOverlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liverMol Pharmacol20046614405215371561
   PubMed Web of Science ®Google Scholar
• ArakawaRHayashiMRemaleyATPhosphorylation and stabilization of ATP binding cassette transporter A1 by synthetic amphiphilic helical peptidesJ Biol Chem2004279862172014701850
   PubMed Web of Science ®Google Scholar
• ArakawaHQianJYBaatarDLocal expression of platelet-activating factor-acetylhydrolase reduces accumulation of oxidized lipoproteins and inhibits inflammation, shear stress-induced thrombosis, and neointima formation in balloon-injured carotid arteries in nonhyperlipidemic rabbitsCirculation20051113302915956136
   PubMed Web of Science ®Google Scholar
• AthyrosVGPapageorgiouAADemitriadesDSAtorvastatin versus four statin-fibrate combinations in patients with familial combined hyperlipidaemiaJ Cardiovasc Risk2002933911984215
   PubMedGoogle Scholar
• BarbierOTorraIPDuguayYPleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosisArterioscler Thromb Vasc Biol2002227172612006382
   PubMed Web of Science ®Google Scholar
• BarrDPRussEMEderHAProtein-lipid relationships in human plasmaAm J Med19511148014885223
   PubMed Web of Science ®Google Scholar
• BarterPJBrewerHBChapmanMJCholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosisArterioscler Thromb Vasc Biol200323160712588754
   PubMed Web of Science ®Google Scholar
• BarterPJNichollsSRyeKAAntiinflammatory properties of HDLCirc Res200487647215486323
   PubMedGoogle Scholar
• BadimonJJBadimonLFusterVRegression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbitJ Clin Invest1990851234412318976
   PubMed Web of Science ®Google Scholar
• BelalcazarLMBallantyneCMDefining specific goals of therapy in treating dyslipidemia in the patient with low high-density lipoprotein cholesterolProg Cardiovasc Dis199841151749790415
   PubMed Web of Science ®Google Scholar
• BerglundLOliverEHFontanezNHDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjectsAm J Clin Nutr199970992100010584043
   PubMed Web of Science ®Google Scholar
• BoekholdtSMKuivenhovenJAWarehamNJPlasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population studyCirculation200411014182315337694
   PubMed Web of Science ®Google Scholar
• BodziochMOrsoEKluckenJThe gene encoding ATP-binding cassette transporter 1 is mutated in Tangier diseaseNat Genet1999223475110431237
   PubMed Web of Science ®Google Scholar
• Bonnefont-RousselotDTherondPBeaudeuxJLHigh density lipoproteins (HDL) and the oxidative hypothesis of atherosclerosisClin Chem Lab Med1999379394810616747
   PubMed Web of Science ®Google Scholar
• BrewerHBJrRemaleyATNeufeldEBRegulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular diseaseArterioscler Thromb Vasc Biol20042417556015319263
   PubMed Web of Science ®Google Scholar
• BrousseauMEDiffenderferMRMillarJSEffects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretionArterioscler Thromb Vasc Biol20052510576415761191
   PubMed Web of Science ®Google Scholar
• BrousseauMSchaeferEJWolfeMLEffects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterolN Engl J Med200435015051515071125
   PubMed Web of Science ®Google Scholar
• BrownBGZhaoXQChaitASimvastatin and niacin, anti-oxidant vitamins, or the combination for the prevention of coronary diseaseN Engl J Med200134515839211757504
   PubMed Web of Science ®Google Scholar
• BruemmerDLawRELiver x receptors: potential novel targets in cardiovascular diseasesCurr Drug Targets Cardiovasc Haematol Disord200555334016503873
   PubMedGoogle Scholar
• CalabresiLGomaraschiMFranceschiniGEndothelial protection by high-density lipoproteins: from bench to bedsideArterioscler Thromb Vasc Biol20032317243112969988
   PubMed Web of Science ®Google Scholar
• CannonCPBraunwaldEMcCabeCHIntensive versus moderate lipid lowering with statins after acute coronary syndromesN Engl J Med2004350149550415007110
   PubMed Web of Science ®Google Scholar
• CarsonSDPlasma high density lipoproteins inhibit the activation of coagulation factor X by factor VIIa and tissue factorFEBS Lett198113237406795061
   PubMed Web of Science ®Google Scholar
• CastelliWPAndersonKWilsonPWLipids and risk of coronary heart disease. The Framingham StudyAnn Epidemiol199222381342260
   PubMedGoogle Scholar
• ChawlaABoisvertWALeeCHA PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesisMol Cell200171617111172721
   PubMed Web of Science ®Google Scholar
• ChiesaGMonteggiaEMarchesiMRecombinant apolipoprotein A-I (Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaksCirc Res2002909748012016263
   PubMed Web of Science ®Google Scholar
• ClarkRWSutfinTARuggeriRBRaising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapibArterioscler Thromb Vasc Biol200424490714739125
   PubMed Web of Science ®Google Scholar
• CraigWYPalomakiGEHaddowJECigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published dataBMJ198929878482496857
   PubMed Web of Science ®Google Scholar
• CrouseJRFrohlichJOseLEffects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-IAm J Cardiol19998314767A710335764
   PubMed Web of Science ®Google Scholar
• DarbonJMTournierJFTauberJPPossible role of protein phosphorylation in the mitogenic effect of high density lipoproteins on cultured vascular endothelial cellsJ Biol Chem198626180023486870
   PubMed Web of Science ®Google Scholar
• DattaGChaddhaMHamaSEffects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptideJ Lipid Res200142109610411441137
   PubMed Web of Science ®Google Scholar
• DattiloAMKris-EthertonPMEffects of weight reduction on blood lipids and lipoproteins: a meta-analysisAm J Clin Nutr19925632081386186
   PubMed Web of Science ®Google Scholar
• DavidsonMHCombination therapy for dyslipidemia: safety and regulatory considerationsAm J Cardiol20029050K60K
   PubMed Web of Science ®Google Scholar
• De GroothGJKlerkxAHStroesESA review of CETP and its relation to atherosclerosisJ Lipid Res20044519677415342674
   PubMed Web of Science ®Google Scholar
• De GroothGJKuivenhovenJAStalenhoefAFEfficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response studyCirculation200210521596511994249
   PubMed Web of Science ®Google Scholar
• DespresJPIncreasing high-density lipoprotein cholesterol: an update on fenofibrateAm J Cardiol20018830N6N11423054
   PubMed Web of Science ®Google Scholar
• DevinePJTurcoMATaylorAJDesign and Rationale of the ARBITER 6 Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol)-6-HDL and LDL Treatment Strategies in Atherosclerosis (HALTS)Cardiovasc Drugs Ther200721221517404825
   PubMed Web of Science ®Google Scholar
• DimayugaPZhuJOguchiSReconstituted HDL containing human apolipoprotein A-1 reduces VCAM-1 expression and neointima formation following periadventitial cuff-induced carotid injury in apoE null miceBiochem Biophys Res Commun1999264465810529386
   PubMed Web of Science ®Google Scholar
• DownsJRClearfieldMWeisSPrimary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention StudyJAMA199827916152229613910
   PubMed Web of Science ®Google Scholar
• DurstineJLGrandjeanPWDavisPGBlood lipid and lipoprotein adaptations to exercise: a quantitative analysisSports Med20013110336211735685
   PubMed Web of Science ®Google Scholar
• DuvergerNKruthHEmmanuelFInhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbitsCirculation19969471378772693
   PubMed Web of Science ®Google Scholar
• ElkhalilLMajdZBakirRFish-eye disease: structural and in vivo metabolic abnormalities of high-density lipoproteinsMetabolism199746474839160810
   PubMed Web of Science ®Google Scholar
• EllenRLMcPhersonRLong-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemiaAm J Cardiol19988160B65B
   PubMed Web of Science ®Google Scholar
• EllisonRCZhangYQureshiMMLifestyle determinants of high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute Family Heart StudyAm Heart J20041475293514999205
   PubMed Web of Science ®Google Scholar
• EricssonCGHamstenANilssonJAngiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patientsLancet1996347849538622389
   PubMed Web of Science ®Google Scholar
• ErikssonMCarlsonLAMiettinenTAStimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humansCirculation1999100594810441095
   PubMed Web of Science ®Google Scholar
• EverettLGalliACrabbDThe role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and diseaseLiver200020191910902968
   PubMedGoogle Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsSummary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)JAMA19932693015238501844
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsExecutive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA200128524869711368702
   PubMed Web of Science ®Google Scholar
• FarnierMCerivastatin in the treatment of mixed hyperlipidemia: the RIGHT study. The Cerivastatin Study Group. Cerivastatin Gemfibrozil Hyperlipidemia TreatmentAm J Cardiol19988247J51J
   PubMed Web of Science ®Google Scholar
• FarnierMPortalJJMaigretPEfficacy of atorvastatin compared with simvastatin in patients with hypercholesterolemiaJ Cardiovasc Pharmacol Ther20005273210687671
   PubMedGoogle Scholar
• ForresterJSMakkarRShahPKIncreasing high-density lipoprotein cholesterol in dyslipidemia by cholesteryl ester transfer protein inhibition: an update for cliniciansCirculation200511118475415824213
   PubMed Web of Science ®Google Scholar
• ForteTMNicholsAVKraussRMFamilial apolipoprotein AI and apolipoprotein CIII deficiency. Subclass distribution, composition, and morphology of lipoproteins in a disorder associated with premature atherosclerosisJ Clin Invest1984741601136501564
   PubMed Web of Science ®Google Scholar
• FranceschiniGSirtoriCRCapursoA2A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian familyJ Clin Invest1980668929007430351
   PubMed Web of Science ®Google Scholar
• FranconeOLFieldingCJFieldingPEDistribution of cell-derived cholesterol among plasma lipoproteins: a comparison of three techniquesJ Lipid Res19903121952002090713
   PubMed Web of Science ®Google Scholar
• FreemanDJCaslakeMJGriffinBAThe effect of smoking on post-heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin:cholesterol acyl transferase activities in human plasmaEur J Clin Invest199828584919726040
   PubMed Web of Science ®Google Scholar
• FrickMHSyvanneMNieminenMSPrevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study GroupCirculation1997962137439337181
   PubMed Web of Science ®Google Scholar
• FriedewaldVEBrewerHBGrundySMThe Editor’s Roundtable: High-Density Lipoprotein CholesterolAm J Cardiol200799169870517560878
   PubMed Web of Science ®Google Scholar
• FunkeHvon EckardsteinAPritchardPHA molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activityProc Natl Acad Sci199188485592052566
   PubMed Web of Science ®Google Scholar
• FurbeeJWJrFranconeOParksJSIn vivo contribution of LCAT to apolipoprotein B lipoprotein cholesteryl esters in LDL receptor and apolipoprotein E knockout miceJ Lipid Res2002434283711893779
   PubMed Web of Science ®Google Scholar
• GanjiSHKamannaVSKashyapMLNiacin and cholesterol: role in cardiovascular disease (review)J Nutr Biochem20031429830512873710
   PubMed Web of Science ®Google Scholar
• GarberDWDattaGChaddhaMA new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosisJ Lipid Res2001425455211290826
   PubMed Web of Science ®Google Scholar
• GazianoJMBuringJEBreslowJLModerate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarctionN Engl J Med19933291829348247033
   PubMed Web of Science ®Google Scholar
• GerasimovaEPerovaNOzerovaIThe effect of dietary n-3 polyunsaturated fatty acids on HDL cholesterol in Chukot residents vs muscovitesLipids19912626151907706
   PubMed Web of Science ®Google Scholar
• GervoisPFruchartJCStaelsBDrug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptorsNat Clin Pract Endocrinol Metab200731455617237841
   PubMedGoogle Scholar
• GlomsetJAThe plasma lecithin:cholesterol acyltransferase reactionJ Lipid Res19689155674868699
   PubMed Web of Science ®Google Scholar
• GoldbourtUBeharSReicher-ReissHRationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial)Am J Cardiol1993719099158465780
   PubMed Web of Science ®Google Scholar
• GordonDJProbstfieldJLGarrisonRJHigh-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studiesCirculation1977798152642759
   PubMedGoogle Scholar
• GordonTCastelliWPHjortlandMCHigh density lipoprotein as a protective factor against coronary heart disease. The Framingham StudyAm J Med62570714193398
   PubMed Web of Science ®Google Scholar
• GrahamAHassallDGRafiqueSEvidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoproteinAtherosclerosis19971351932049430369
   PubMed Web of Science ®Google Scholar
• GriffinJHKojimaKBankaCLHigh-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein CJ Clin Invest1999103219279916134
   PubMed Web of Science ®Google Scholar
• GrundySMCleemanJIMerzCNImplications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesJ Am Coll Cardiol2004447203215358046
   PubMed Web of Science ®Google Scholar
• GuptaAKRossEAMyersJNIncreased reverse cholesterol transport in athletesMetabolism199342684908510511
   PubMed Web of Science ®Google Scholar
• JoyceCBrewerBHFreemanLStudy of ABCA1 function in transgenic miceArterioscler Thromb Vasc Biol2003239657112615681
   PubMed Web of Science ®Google Scholar
• HarperCRJacobsonTANew perspectives on the management of low levels of high-density lipoprotein cholesterolArch Intern Med199915910495710335681
   PubMed Web of Science ®Google Scholar
• HayekTOiknineJDanknerGHDL apolipoprotein A-I attenuates oxidative modification of low density lipoprotein: studies in transgenic miceEur J Clin Chem Clin Biochem19953372158608194
   PubMedGoogle Scholar
• HegeleRAParaoxonase genes and diseaseAnn Med1999312172410442677
   PubMed Web of Science ®Google Scholar
• HeinonenTMSteinEWeissSRThe lipid-lowering effects of atorvastatin, a new HMG-CoA reductase inhibitor: results of a randomized, double-masked studyClin Ther199618853638930429
   PubMed Web of Science ®Google Scholar
• HiranoKYamashitaSKugaYAtherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipaseArterioscler Thromb Vasc Biol1995151849567583564
   PubMed Web of Science ®Google Scholar
• HiranoKYamashitaSMatsuzawaYPros and cons of inhibiting cholesteryl ester transfer proteinCurr Opin Lipidol2000115899611086331
   PubMed Web of Science ®Google Scholar
• HondaHMLeitingerNFrankelMHigh-density lipoprotein increases intracellular calcium levels by releasing calcium from internal stores in human endothelial cellsAtherosclerosis1999229930610217358
   PubMedGoogle Scholar
• HoneyKDrug designed to raise HDL levels falls downJ Clin Invest200711728217273546
   PubMed Web of Science ®Google Scholar
• HuttunenJThe Helsinki Heart Study: central findings and clinical implicationsAnn Med19912315592069792
   PubMed Web of Science ®Google Scholar
• IbanezBShort-term treatment with Apo AI Milano indues atherosclerotic plaque regression and signs of plaque stabilization: in vivo MRI study2007Paper presented at: Annual Meeting of the American College of CardiologyMarch 24-27New Orleans, LA
   Google Scholar
• IkewakiKNishiwakiMSakamotoTIncreased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiencyJ Clin Invest1995961573817657828
   PubMed Web of Science ®Google Scholar
• ImamuraHTeshimaKMiyamotoNCigarette smoking, high-density lipoprotein cholesterol subfractions, and lecithin: cholesterol acyltransferase in young womenMetabolism2002511313612370852
   PubMed Web of Science ®Google Scholar
• InazuABrownMLHeslerCBIncreased high-density lipoprotein levels caused by a common cholesterylester transfer protein gene mutationN Engl J Med1990323123482215607
   PubMed Web of Science ®Google Scholar
• InoueIItohFAoyagiSFibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaBBiochem Biophys Res Commun2002290131911779144
   PubMed Web of Science ®Google Scholar
• JansenHHepatic lipase: friend or foe and under what circumstances?Curr Atheroscler Rep20046343715296699
   PubMedGoogle Scholar
• JinFYKamannaVSKashyapMLNiacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transportArterioscler Thromb Vasc Biol199717202089351367
   PubMed Web of Science ®Google Scholar
• JonesP2006International Symposium on AtherosclerosisJune 18-22Rome, Italy
   Google Scholar
• JosephSBMcKilliginEPeiLSynthetic LXR ligand inhibits the development of atherosclerosis in miceProc Natl Acad Sci USA2002997604912032330
   PubMed Web of Science ®Google Scholar
• KannelWBHigh-density lipoproteins: epidemiologic profile and risks of coronary artery diseaseAm J Cardiol1983529B12B
   PubMed Web of Science ®Google Scholar
• KaplinskyE1998Data presented at European Society of Cardiology MeetingVienna, Austria
   Google Scholar
• KasteleinJJIsaacsohnJLOseLComparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levelsAm J Cardiol200086221310913488
   PubMed Web of Science ®Google Scholar
• KennedyMABarreraGCNakamuraKABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulationCell Metab200511213116054053
   PubMed Web of Science ®Google Scholar
• KhavkinTNNikolai Nikolaevich AnitschkowBeitr Pathol197515630112130900
   PubMedGoogle Scholar
• KlerkxAHde GroothGJZwindermanAHCholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS)Eur J Clin Invest20043421814984434
   PubMed Web of Science ®Google Scholar
• KoizumiJInazuAYagiKSerum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiencyAtherosclerosis199190189961759989
   PubMed Web of Science ®Google Scholar
• KokkinosPFHollandJCNarayanPMiles run per week and high-density lipoprotein cholesterol levels in healthy, middle-aged men. A dose-response relationshipArch Intern Med1995155415207848025
   PubMed Web of Science ®Google Scholar
• KostnerKMSmithJLSmithBEPresentation. A novel extracorporeal plasma delipidation procedure for the treatment of atherosclerosis200273rd Eur Athero Soc Meeting
   Google Scholar
• Kris-EthertonPMHarrisWSAppelLJFish consumption, fish oil, omega-3 fatty acids, and cardiovascular diseaseCirculation200210627475712438303
   PubMed Web of Science ®Google Scholar
• KuivenhovenJAJukemaJWZwindermanAHThe role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study GroupN Engl J Med199833886939420339
   PubMed Web of Science ®Google Scholar
• KujiraokaTNanjeeMNOkaTEffects of intravenous apolipoprotein A-I/phosphatidylcholine discs on LCAT, PLTP, and CETP in plasma and peripheral lymph in humansArterioscler Thromb Vasc Biol2003231653912893687
   PubMed Web of Science ®Google Scholar
• KuvinJTRametMEPatelARA novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial nitric oxide synthase expressionAm Heart J20021441657212094204
   PubMed Web of Science ®Google Scholar
• KwiterovichPOJrThe antiatherogenic role of high-density lipoprotein cholesterolAm J Cardiol19988213Q21Q9671001
   PubMed Web of Science ®Google Scholar
• LalaDSThe liver X receptorsCurr Opin Investig Drugs2005693443
   PubMedGoogle Scholar
• LaRosaJCGrundySMWatersDDIntensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary DiseaseN Engl J Med200535214253515755765
   PubMed Web of Science ®Google Scholar
• LevkauBHermannSTheilmeierSHigh-density lipoprotein stimulates myocardial perfusion in vivoCirculation20041103355915545521
   PubMedGoogle Scholar
• LewisGFDeterminants of plasma HDL concentrations and reverse cholesterol transportCurr Opin Cardiol2006213455216755204
   PubMed Web of Science ®Google Scholar
• LewisGFRaderDJNew insights into the regulation of HDL metabolism and reverse cholesterol transportCirc Res20059612213215976321
   PubMed Web of Science ®Google Scholar
• LiXChyuKYNetoJRDifferential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null miceCirculation20041101701515353488
   PubMed Web of Science ®Google Scholar
• LichtensteinAHAusmanLMJalbertSMEffects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levelsN Engl J Med199934019334010379016
   PubMed Web of Science ®Google Scholar
• LiuPYLiYHWuHLPlatelet-activating factor-acetylhydrolase A379V (exon 11) gene polymorphism is an independent and functional risk factor for premature myocardial infarctionJ Thromb Haemost200641023816689754
   PubMed Web of Science ®Google Scholar
• Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study GroupPrevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levelsN Engl J Med19983391349579841303
   PubMed Web of Science ®Google Scholar
• LundEGPetersonLBAdamsADDifferent roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtypeBiochem Pharmacol2006714536316325781
   PubMed Web of Science ®Google Scholar
• MacknessMIDurringtonPMacknessBParaoxonase 1 activity, concentration and genotype in cardiovascular diseaseCurr Opin Lipidol20041539940415243212
   PubMed Web of Science ®Google Scholar
• MacknessMIDurringtonPNMacknessBHow high-density lipoprotein protects against the effects of lipid peroxidationCurr Opin Lipidol200011383810945720
   PubMed Web of Science ®Google Scholar
• MaedaKNoguchiYFukuiTThe effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysisPrev Med2003372839014507483
   PubMed Web of Science ®Google Scholar
• ManninenVTenkanenLKoskinenPJoint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatmentCirculation19928537451728471
   PubMed Web of Science ®Google Scholar
• ManttariMHuttunenJKKoskinenPLipoproteins and coronary heart disease in the Helsinki Heart StudyEur Heart J199011Suppl H26312073911
   PubMed Web of Science ®Google Scholar
• MarcilMYuLKrimbouLCellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiencyArterioscler Thromb Vasc Biol199919159699888879
   PubMed Web of Science ®Google Scholar
• MarchesiMBoothEADavisTApolipoprotein A-IMilano and 1-palmitoyl-2-oleoyl phosphatidylcholine complex (ETC-216) protects the in vivo rabbit heart from regional ischemia-reperfusion injuryJ Pharmacol Exp Ther200431110233115375174
   PubMed Web of Science ®Google Scholar
• MartinGDuezHBlanquartCStatin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-IJ Clin Invest200110714233211390424
   PubMed Web of Science ®Google Scholar
• MeksawanKPendergastDRLeddyJJEffect of low and high fat diets on nutrient intakes and selected cardiovascular risk factors in sedentary men and womenJ Am Coll Nutr2004231314015047679
   PubMed Web of Science ®Google Scholar
• MeroNVan TolAScheekLMDecreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in nor-molipidemic smoking men: relations with lipid transfer proteins and LCAT activitiesJ Lipid Res19983914935029684753
   PubMed Web of Science ®Google Scholar
• MezdourHJonesRDengremontCHepatic lipase deficiency increases plasma cholesterol but reduces susceptibility to atherosclerosis in apolipoprotein E-deficient miceJ Biol Chem19972721357059153204
   PubMed Web of Science ®Google Scholar
• McDonaldMCDhadlyPCockerillGWReconstituted high-density lipoprotein attenuates organ injury and adhesion molecule expression in a rodent model of endotoxic shockShock200320551714625480
   PubMed Web of Science ®Google Scholar
• McNeishJAielloRJGuyotDHigh density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1Proc Nat Acad Sci USA20009742455010760292
   PubMed Web of Science ®Google Scholar
• MiaoBZondloSGibbsSRaising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulatorJ Lipid Res2004451410715145986
   PubMed Web of Science ®Google Scholar
• MillerMKwiterovichPOIsolated low HDL-cholesterol as an important risk factor for coronary heart diseaseEur Heart J199011Suppl H9142073916
   PubMedGoogle Scholar
• MillerNEThelleDSFordeOHThe Tromso heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control studyLancet19771965867464
   PubMed Web of Science ®Google Scholar
• MineoCDeguchiHGriffinJHEndothelial and antithrombotic actions of HDLCirc Res20069813526416763172
   PubMed Web of Science ®Google Scholar
• MoestrupSKKozyrakiRCubilin, a high-density lipoprotein receptorCurr Opin Lipidol2000111334010787174
   PubMed Web of Science ®Google Scholar
• MoffattRJEffects of cessation of smoking on serum lipids and high density lipoprotein-cholesterolAtherosclerosis1988748593214483
   PubMed Web of Science ®Google Scholar
• MortonREGreeneDJSuppression of lipid transfer inhibitor protein activity by oleate. A novel mechanism of cholesteryl ester transfer protein regulation by plasma free fatty acidsArterioscler Thromb Vasc Biol199717304189409291
   PubMedGoogle Scholar
• MotojimaKPetersJMGonzalezFJPPAR alpha mediates peroxisome proliferator-induced transcriptional repression of nonperoxisomal gene expression in mouseBiochem Biophys Res Commun199723015589020034
   PubMedGoogle Scholar
• MRC/BHFHeart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experienceEur Heart J19962072541
   Google Scholar
• Multiple Risk Factor Intervention TrialRisk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research GroupJAMA19822481465777050440
   PubMed Web of Science ®Google Scholar
• NaikSUWangXDa SilvaJSPharmacological activation of liver X receptors promotes reverse cholesterol transport in vivoCirculation200611390716365197
   PubMed Web of Science ®Google Scholar
• NanjeeMNCookeCJGarvinRIntravenous apoA-I/lecithin discs increase pre-beta-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humansJ Lipid Res20014215869311590214
   PubMed Web of Science ®Google Scholar
• NaqviTZShahPKIveyPAEvidence that high-density lipoprotein cholesterol is an independent predictor of acute platelet-dependent thrombus formationAm J Cardiol199991011710569655
   PubMedGoogle Scholar
• NavabMAnantharamaiahGMReddySTApolipoprotein A-I mimetic peptides and their role in atherosclerosis preventionNat Clin Pract Cardiovasc Med20063540716990839
   PubMedGoogle Scholar
• NavabMAnantharamaiahGMReddySTHuman apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversalCurr Opin Lipidol200415645915529023
   PubMed Web of Science ®Google Scholar
• NavabMBerlinerJAWatsonADThe Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial LectureArterioscler Thromb Vasc Biol199616831428673557
   PubMed Web of Science ®Google Scholar
• NissenSETardifJCNichollsSJEffect of torcetrapib on the progression of coronary atherosclerosisN Engl J Med200735613041617387129
   PubMed Web of Science ®Google Scholar
• NissenSETsunodaTTuzcuEMEffect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trialJAMA2003290229230014600188
   PubMed Web of Science ®Google Scholar
• NobecourtEDaviesMJBrownBEThe impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin: cholesterol acyltransferaseDiabetologia2007506435317216278
   PubMed Web of Science ®Google Scholar
• NoferJRLevkauBWolinskaISuppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipidsJ Biol Chem200127634480511432865
   PubMed Web of Science ®Google Scholar
• NorataGDCallegariEMarchesiMHigh-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cellsCirculation200511128051115911702
   PubMed Web of Science ®Google Scholar
• O’ConnellBJDenisMGenestJHigh-density lipoproteins and endothelial functionCirculation200110419788311602504
   PubMed Web of Science ®Google Scholar
• OliverWRShenkJLSnaithMRA selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transportProc Natl Acad Sci20019853061111309497
   PubMed Web of Science ®Google Scholar
• OramJFLawnRMABCA1: The gatekeeper for eliminating excess tissue cholesterolJ Lipid Res2001421173911483617
   PubMed Web of Science ®Google Scholar
• OutRHoekstraMHildebrandRBMacrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient miceArterioscler Thromb Vasc Biol200626229530016857950
   PubMed Web of Science ®Google Scholar
• PapadakisJAGanotakisESJagroopIAStatin + fibrate combination therapy fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular diseaseInt J Cardiol199932374410402106
   PubMedGoogle Scholar
• PauciulloPBorgninoCPaolettiREfficacy and safety of a combination of fluvastatin and bezafibrate in patients with mixed hyperlipidaemia (FACT study)Atherosclerosis20001504293610856536
   PubMed Web of Science ®Google Scholar
• PloschTKokTBloksVWIncreased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1J Biol Chem200227733870712105210
   PubMed Web of Science ®Google Scholar
• PoonMZhangXDunskyKApolipoprotein(a) induces monocyte chemotactic activity in human vascular endothelial cellsCirculation199796251499355887
   PubMed Web of Science ®Google Scholar
• QureshiAIGilesWHCroftJBApolipoproteins A-1 and B and the likelihood of non-fatal stroke and myocardial infarction – data from The Third National Health and Nutrition Examination SurveyMed Sci Monit20028CR311612011770
   PubMedGoogle Scholar
• RimmEBWilliamsPFosherKModerate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factorsBMJ19993191523810591709
   PubMed Web of Science ®Google Scholar
• RittershausCWMillerDPThomasLJVaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosisArterioscler Thromb Vasc Biol20002021061210978256
   PubMed Web of Science ®Google Scholar
• RossnerSBjorvellHEarly and late effects of weight loss on lipoprotein metabolism in severe obesityAtherosclerosis198764125303606709
   PubMedGoogle Scholar
• RubenstrunkAHanfRHumDWSafety issues and prospects for future generations of PPAR modulatorsBiochim Biophys Acta2007 Epub ahead of print
   PubMedGoogle Scholar
• RubinEMKraussRMSpanglerEAInhibition of early atherogenesis in transgenic mice by human apolipoprotein AINature199135326571910153
   PubMed Web of Science ®Google Scholar
• RubinsHBDavenportJBabikianVReduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol. The Veterans Affairs HDL Intervention Trial (VA-HIT)Circulation200110328283311401940
   PubMed Web of Science ®Google Scholar
• SacksFMPfefferMAMoyeLAThe effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigatorsN Engl J Med1996335100198801446
   PubMed Web of Science ®Google Scholar
• SakaiNMatsuzawaYHiranoKDetection of two species of low density lipoprotein particles in cholesteryl ester transfer protein deficiencyArterioscler Thromb1991117191988006
   PubMedGoogle Scholar
• SakuKAhmadMGlas-GreenwaltPActivation of fibrinolysis by apolipoproteins of high density lipoproteins in manThromb Res198539184035643
   PubMed Web of Science ®Google Scholar
• SavagePDBrochuMAdesPAGender alters the high-density lipoprotein cholesterol response to cardiac rehabilitationJ Cardiopulm Rehabil2004242485415286530
   PubMedGoogle Scholar
• Scandinavian Simvastatin Survival Study GroupRandomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)Lancet1994344138397968073
   PubMed Web of Science ®Google Scholar
• SchaeferJRSchweerHIkewakiKMetabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery diseaseAtherosclerosis19991441778410381291
   PubMed Web of Science ®Google Scholar
• SchmitzGDrobnikWATP-binding cassette transporters in macrophages: promising drug targets for treatment of cardiovascular diseaseCurr Opin Investig Drugs200238538
   PubMedGoogle Scholar
• SchmitzGLangmannTHigh-density lipoproteins and ATP-binding cassette transporters as targets for cardiovascular drug therapyCurr Opin Investig Drugs2005690719
   PubMedGoogle Scholar
• SegrestJPLiLAnantharamaiahGMStructure and function of apolipoprotein A-I and high-density lipoproteinCurr Opin Lipidol2000111051510787171
   PubMed Web of Science ®Google Scholar
• ShahPKEmerging HDL-based therapies for atherothrombotic vascular diseaseCurr Treat Options Cardiovasc Med20079607017378977
   PubMedGoogle Scholar
• ShahPKLow-density lipoprotein lowering and atherosclerosis progression: does more mean less?Circulation200210620394012379568
   PubMed Web of Science ®Google Scholar
• ShahPKAminJLow high density lipoprotein level is associated with increased restenosis rate after coronary angioplastyCirculation1992851279851555271
   PubMed Web of Science ®Google Scholar
• ShahPKKaulSNilssonJExploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part IICirculation2001104249850211705831
   PubMedGoogle Scholar
• ShahPKNilssonJKaulSEffects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient miceCirculation19989778059498542
   PubMed Web of Science ®Google Scholar
• ShihDMGuLXiaYRMice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosisNature199839428479685159
   PubMed Web of Science ®Google Scholar
• SoloffLAIntermediate lipoproteins, atherosclerosis, and GofmanCirculation1998977089495311
   PubMed Web of Science ®Google Scholar
• StaelsBDallongevilleJAuwerxJMechanism of action of fibrates on lipid and lipoprotein metabolismCirculation1998982088939808609
   PubMed Web of Science ®Google Scholar
• StaelsBVu-DacNKosykhVAFibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibratesJ Clin Invest199595705127860752
   PubMed Web of Science ®Google Scholar
• StefanickMLMackeySSheehanMEffects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterolN Engl J Med199833912209647874
   PubMed Web of Science ®Google Scholar
• SuganoMMakinoNSawadaSEffect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbitsJ Biol Chem1998273503369478952
   PubMed Web of Science ®Google Scholar
• SuganoMTsuchidaKMakinoNHigh-density lipoproteins protect endothelial cells from tumor necrosis factor-alpha-induced apoptosisBiochem Biophys Res Commun2000272872610860844
   PubMed Web of Science ®Google Scholar
• SugataniJMiwaMKomiyamaYHigh-density lipoprotein inhibits the synthesis of platelet-activating factor in human vascular endothelial cellsJ Lipid Mediat Cell Signal19961373888998599
   PubMedGoogle Scholar
• SviridovDKingwellBHoangASingle session exercise stimulates formation of pre beta 1-HDL in leg muscleJ Lipid Res200344522612562839
   PubMed Web of Science ®Google Scholar
• SviridovDMiyazakiOTheodoreKDelineation of the role of pre-beta 1-HDL in cholesterol efflux using isolated pre-beta 1-HDLArterioscler Thromb Vasc Biol2002221482812231570
   PubMedGoogle Scholar
• SzaparyPORaderDJThe triglyceride-high-density lipoprotein axis: an important target of therapy?Am Heart J20041482112115308990
   PubMed Web of Science ®Google Scholar
• TallARYvan-CharvetLWangNThe failure of torcetrapib: was it the molecule or the mechanism?Arterioscler Thromb Vasc Biol2007272576017229967
   PubMed Web of Science ®Google Scholar
• TardifJCEffect of reconstituted high density lipoprotein infusions on coroanry atherosclerosis2007Paper presented at Annual Meeting of the American College of CardiologyMarch 24–27New Orleans, LA
   Google Scholar
• TaylorAJSullenbergerLELeeHJArterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statinsCirculation20041103512715537681
   PubMed Web of Science ®Google Scholar
• TerasakNHiroshimaAKoieyamaTT-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient miceFEBS Lett200353661112586329
   PubMed Web of Science ®Google Scholar
• ThorntonJSymesCHeatonKModerate alcohol intake reduces bile cholesterol saturation and raises HDL cholesterolLancet19832819226137650
   PubMed Web of Science ®Google Scholar
• Tilly-KiesiMTikkanenMJEffects of lovastatin and gemfibrozil on high-density lipoprotein subfraction density and composition in patients with familial hypercholesterolemiaJ Lab Clin Med19921201103101613316
   PubMed Web of Science ®Google Scholar
• TothPPHigh-density lipoprotein as a therapeutic target: clinical evidence and treatment strategiesAm J Cardiol20059650K58K discussion 34K–35K
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human ServicesPhysical activity and health: A report of the Surgeon General: Adolescents and young adults fact sheet1999 http://www.cdc.gov/nccdphp/sgr/adoles.htm
   Google Scholar
• VanceDEVan den BoschHCholesterol in the year 2000Biochim Biophys Acta200015291811111073
   PubMed Web of Science ®Google Scholar
• WilsonPWAbbottRDCastelliWPHigh density lipoprotein cholesterol and mortality. The Framingham Heart StudyArteriosclerosis19888737413196218
   PubMedGoogle Scholar
• Van der GaagMSvan TolAVermuntSHAlcohol consumption stimulates early steps in reverse cholesterol transportJ Lipid Res20014220778311734581
   PubMed Web of Science ®Google Scholar
• VaughanAMOramJFABCG1 redistributes cell cholesterol to domains removable by high density lipoprotein but not by lipid-depleted apolipoproteinsJ Biol Chem200528030150715994327
   PubMed Web of Science ®Google Scholar
• VegaGLMaPTCaterNBEffects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndromeAm J Cardiol2003919566012686335
   PubMed Web of Science ®Google Scholar
• VenkateswaranALaffitteBAJosephSBControl of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alphaProc Natl Acad Sci2000971209710211035776
   PubMed Web of Science ®Google Scholar
• WangMBriggsMRHDL: the metabolism, function, and therapeutic importanceChem Rev200410411193714719972
   PubMed Web of Science ®Google Scholar
• WatsonADBerlinerJAHamaSYProtective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoproteinJ Clin Invest1995962882918675659
   PubMed Web of Science ®Google Scholar
• West of Scotland Coronary Prevention GroupWest of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trialsLancet1996348133913428918276
   PubMed Web of Science ®Google Scholar
• WestmanJRoobolCCarlsonLAIn vitro reverse cholesterol transport from THP-1-derived macrophage-like cells with synthetic HDL particles consisting of proapolipoprotein A1 or apolipoprotein A1 and phosphatidylcholineScand J Clin Lab Invest19955523337624733
   PubMed Web of Science ®Google Scholar
• WilliamsPTInteractive effects of exercise, alcohol, and vegetarian diet on coronary artery disease risk factors in 9242 runners: the National Runners’ Health StudyAm J Clin Nutr19976611972069356539
   PubMed Web of Science ®Google Scholar
• WilliamsPTThe relationships of vigorous exercise, alcohol, and adiposity to low and high high-density lipoprotein-cholesterol levelsMetabolism200453700915164315
   PubMed Web of Science ®Google Scholar
• WoodPDStefanickMLDreonDMChanges in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exerciseN Engl J Med1988319117393173455
   PubMed Web of Science ®Google Scholar
• YamashitaSMatsuzawaYOkazakiMSmall polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activityAtherosclerosis1988707123355618
   PubMed Web of Science ®Google Scholar
• YuhannaISZhuYCoxBEHigh-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthaseNat Med20017853711433352
   PubMed Web of Science ®Google Scholar
• ZeiherAMSchachlingerBHohnloserSHCoronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosisCirculation1994892525328205660
   PubMed Web of Science ®Google Scholar
• ZhangYZanottiIReillyMPOverexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivoCirculation2003108661312900335
   PubMed Web of Science ®Google Scholar